ANAVEX®2-73 (blarcamesine) Receives Compassionate Use Authorization for Pediatric Patients with Rett Syndrome
Health Canada Special Access Program Authorizes ANAVEX®2-73 for patients after successful completion of Open-Label Extension study Granting of requests are also ongoing in United Kingdom and... | June 15, 2023